Gagnon Robert E. 4

What Happened
Robert E. Gagnon, Chief Financial Officer of Opus Genetics (IRD), had 7,842 shares disposed of on April 23, 2026. The shares were sold at a weighted average price of $5.18 per share for gross proceeds of approximately $40,658. This was not a discretionary sale — the shares were sold automatically to satisfy tax withholding obligations arising from a restricted stock unit (RSU) vesting and settlement.

Key Details

• Transaction date: 2026-04-23 (reported on Form 4 filed 2026-04-27).
• Transaction type/codes: S = Sale; F (tax withholding) — sale to cover tax withholding on RSU settlement.
• Quantity and price: 7,842 shares sold; weighted average price $5.18; individual trade prices ranged $5.1828–$5.1901.
• Total proceeds: ~ $40,658 (gross).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timing: Report filed four days after the transaction (Form 4 filed 2026-04-27 for a 2026-04-23 trade); Form 4s are generally due within two business days of the transaction.

Context
This sale was a routine, automatic withholding transaction tied to RSU vesting (not a voluntary market-timing sale). Such tax-withholding disposals are common and generally less informative about an insider’s view of the company than voluntary purchases. If you want the precise breakdown of the multiple individual trade prices within the reported range, the filing notes the reporting person will provide that information upon request.